EUVIMEDOpdag EUVIMED
EditorialOpen access

Editorial: Upadacitinib in Perianal Crohn's Disease

Manjeet Kumar Goyal, Shrinivas Bishu iD

Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (4) · 544-545

DOI: 10.1111/apt.70759 ↗

At a glance

Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-06-02. Written by Manjeet Kumar Goyal and 1 co-authors. Institution: Department of Internal Medicine, Cleveland Clinic Akron General, Akron, Ohio, USA. Cited 1 times so far (Crossref); 10 references. The full text is freely available in PubMed Central.

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Authors and institutions

  • Department of Internal Medicine, Cleveland Clinic Akron General, Akron, Ohio, USA.
  • Division of Gastroenterology and Hepatology, University of Michigan, Ann Arbor, Michigan, USA.

ORCID profiles: Shrinivas Bishu

Cite

APA

Goyal, M. K., & Bishu, S. (2026). Editorial: Upadacitinib in Perianal Crohn's Disease. Alimentary Pharmacology & Therapeutics, 64(4), 544-545. https://doi.org/10.1111/apt.70759

Vancouver

Goyal MK, Bishu S. Editorial: Upadacitinib in Perianal Crohn's Disease. Alimentary Pharmacology & Therapeutics. 2026;64(4):544-545. doi:10.1111/apt.70759

BibTeX
@article{Goyal2026,
  author = {Goyal, Manjeet Kumar and Bishu, Shrinivas},
  title = {Editorial: Upadacitinib in Perianal Crohn's Disease},
  journal = {Alimentary Pharmacology & Therapeutics},
  year = {2026},
  volume = {64},
  number = {4},
  pages = {544--545},
  doi = {10.1111/apt.70759}
}
Start for free →